Complete genome sequence of Peptoclostridium difficile strain Z31 by Felipe L. Pereira et al.
Pereira et al. Gut Pathog  (2016) 8:11 
DOI 10.1186/s13099-016-0095-3
GENOME REPORT
Complete genome sequence 
of Peptoclostridium difficile strain Z31
Felipe L. Pereira1, Carlos A. Oliveira Júnior2, Rodrigo O. S. Silva2, Fernanda A. Dorella1, Alex F. Carvalho1, 
Gabriel M. F. Almeida1, Carlos A. G. Leal1, Francisco C. F. Lobato2† and Henrique C. P. Figueiredo1,3*†
Abstract 
Background: Peptoclostridium (Clostridium) difficile is a spore-forming bacterium responsible for nosocomial infec-
tions in humans. It is recognized as an important agent of diarrhea and colitis in several animal species and a possible 
zoonotic agent. Despite the known importance of P. difficile infection in humans and animals, no vaccine or other 
effective measure to control the disease is commercially available. A possible alternative treatment for P. difficile infec-
tion is the use of a nontoxigenic strain of P. difficile as a competitive exclusion agent. However, a thorough knowledge 
of this strain is necessary for this purpose. We selected P. difficile Z31, a nontoxigenic strain (PCR ribotype 009), for 
investigation because it prevents P. difficile infection in a hamster model.
Results: The genome sequence of P. difficile Z31 is a circular chromosome of 4298,263 bp, with a 29.21 % GC content, 
encoding 4128 proteins, and containing 78 pseudogenes. This strain belongs to ST 3, clade 1, and has five phage 
regions in its genome. Genes responsible for resistance to tetracycline and erythromycin were detected and more 
importantly, Z31 also contains genes that promote spore production and stability, cell attachment, intestinal adher-
ence, and biofilm formation.
Conclusion: In this study, we present the first complete genome sequence of nontoxigenic P. difficile strain Z31. 
When the Z31 genome was compared with those of other isolates available in GenBank, including a draft genome of 
a nontoxigenic strain, several unique regions were evident. Z31 contains no toxin genes, but encodes several non-
toxin virulence factors, which may favor host colonization.
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Background
Peptoclostridium difficile, initially called Bacillus diffi-
cilis, was first isolated from the meconium of newborns 
by Hall and O’Toole in 1935 [1]. The name ‘Clostridium 
difficile’ was made official in 1980 in the Approved Lists 
of Bacterial Names [2] based on a phenotypic study by 
Prevót [3]. Recently, in a study based on 16S rRNA and 
ribosomal protein sequences, Yutin and Galperin [4] pro-
posed the reallocation of some Clostridium species into 
six new genera, renaming C. difficile ‘Peptoclostridium 
difficile’.
The genus Peptoclostridium, in the phylum Firmicutes, 
class Clostridia, order Clostridiales, and family Peptos-
treptococcaceae [4], is characterized by strictly anaero-
bic, motile, pleomorphic Gram-positive bacteria, with 
dimensions of 0.5–1.9  ×  3.0–16.9  µm, which form oval 
subterminal spores (Fig. 1) with a bacillus cell shape. The 
bacteria are spore-forming and mesophilic (20–37  °C), 
with an optimal pH range of neutral to alkaline. They fer-
ment fructose, glucose, levulose, mannitol, mannose, sali-
cin, and usually xylose, but not galactose, glycerol, inulin, 
lactose, raffinose, or sucrose. They are chemoorgano-
trophs and can use yeast extract as their sole carbon and 
energy source and peptone as their nitrogen source. Pep-
toclostridium difficile liquefies gelatin, but does not attack 
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coagulated serum, milk, or meat proteins and is unable to 
reduce sulfate. It is negative for lecithinase, lipase, oxidase, 
and catalase. Acetate is produced as a major end product, 
but it also produces butyrate, formate, isobutyrate, iso-
caproate, isovalerate, lactate, and valerate [3–5].
Until the late 1970s, P. difficile was not recognized as 
pathogenic bacteria. However, in this decade, P. difficile 
and its toxins were related in fecal contents of human 
patients with pseudomembranous colitis [6] and the 
disease was reproduced in hamsters [7], confirming the 
importance of this microorganism as an enteropatho-
gen. Today, this bacterium is known to be the cause of 
P. difficile infection (PDI), the main cause of nosocomial 
diarrhea in humans worldwide and a possible cause of 
diarrhea in general community [8, 9].
In veterinary medicine, P. difficile is the most impor-
tant uncontrolled cause of neonatal diarrhea in piglets in 
the USA and Europe, and also occurs in other domestic 
animals and some wild species [10, 11]. In piglets, CDI 
affects animals to 1–7  days of life, and it was demon-
strated that until 1  day of life, 68–100  % of the animals 
are infected by the microorganism [12, 13]. The disease is 
subclinical, and just few animals show diarrhea, however, 
the infection can affect the development of the animals 
causing economic losses to the farmer [14].
The pathogeny of PDI involves the colonization of colon 
by some toxigenic strain of P. difficile and production of its 
toxins, the toxin A, an enterotoxin, and toxin B, a cytotoxin, 
that act synergistically causing cytoskeleton damages, cell 
rounding, disruption of tight junctions and cell death [15]. 
The genes responsible to produce toxins, the main differ-
ence between toxigenic and nontoxigenic strains, are local-
ized in a pathogenicity locus of 19 kb, called PaLoc [16].
Despite the known importance of P. difficile in 
humans and animals, no vaccine is yet commercially 
available. Studies have shown that recombinant and clas-
sical immunogens expressing toxins A and B can prevent 
the occurrence of diarrhea or reduce the severity of P. dif-
ficile infection (PDI) in a rodent model [17]. These vac-
cines might limit, but cannot prevent, the fecal shedding 
of the microorganism, which is essential because P. dif-
ficile is a nosocomial pathogen. Because this bacterium 
is also a potential zoonotic agent, preventing its colo-
nization of domestic animals should be a priority [10]. 
Among other alternative preventive strategies examined, 
the use of nontoxigenic P. difficile strains to prevent PDI 
has been shown to reduce the occurrence of the disease 
in humans and piglets by preventing their colonization by 
toxigenic strains [18–21].
There has been no report of the complete genome 
sequence of a nontoxigenic P. difficile strain, a necessary 
step in understanding this candidate live vaccine. There-
fore, in this study, we determined the complete genome 
sequence of P. difficile nontoxigenic strain Z31.
Methods
Growth conditions and DNA isolation
Peptoclostridium difficile Z31, ribotype 009, a nontoxi-
genic strain isolated from a healthy dog on February 
1, 2009, in the city of Belo Horizonte (state of Minas 
Gerais, Brazil), was selected for sequencing because it 
prevented PDI in hamster model [22], similar to some 
strains previously reported [23]. This strain was grown 
in Mueller–Hinton agar supplemented with 5  % blood 
and 0.1 % taurocholate at 37 °C under anaerobic condi-
tions for 48–72 h. Its genomic DNA was extracted with 
the Maxwell 16® Research Instrument (Promega, USA) 
combined with lysozyme (10 mg/mL) and proteinase K 
(20  mg/mL). Briefly, cells were incubated overnight in 
lysozyme solution (10  mg/mL) at 37  °C. Proteinase K 
was added and the mixture was incubated at 56  °C for 
30  min. According to the kit instructions: (i) the sam-
ples were lysed in the presence of a chaotropic agent 
and a detergent; (ii) the nucleic acids were bound to 
silica magnetic particles; (iii) the bound particles were 
washed, to isolate them from other cell components; and 
(iv) the nucleic acids were eluted into a formulation for 
sequencing. The extracted DNA was stored at −80  °C 
until analysis.
Genome sequencing and assembly
The genome was sequenced with the Ion Torrent PGM™, 
in a mate-pair sequencing kit with an insert size of 3 kbp 
(~144-fold coverage) and with a fragment sequencing 
400  bp kit (~318-fold coverage). The quality of the raw 
data was analyzed with FastQC [24] and the sequence 
was assembled with the Mira 4.9.1 software [25] and 
Newbler 2.9 (Roche, USA) for the fragment library, and 
Fig. 1 Photomicrograph of Peptoclostridium difficile strain Z31
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with SPAdes 3.5.0 [26] for the mate-pair library (the 
parameters for all the assembler software are shown in 
Additional file 1). This was the ab initio strategy applied 
to all libraries. The larges contigs obtained with New-
bler and Mira were used as input, as trusted-contigs, in 
SPAdes. We obtained 20 scaffolds, with an N50 value 
of 698,574 bp, and the largest scaffold had a length size 
of 1691,449  bp. Gap filling was conducted with CLC 
Genomics Workbench 7 (Qiagen, USA), after the con-
struction of a super scaffold with the CONTIGuator 2.0 
software [27], using the default parameters and P. diffi-
cile strain CD196 (GenBank: NC_013315.1) as the refer-
ence. The gaps in the rRNA operon regions were filled by 
consensus mapping to the reference, and the remaining 
gaps were mapped recursively to the raw data on the gap 
flanks, and it was repeated several times until an overlap 
was found.
Genome annotation
The genome was annotated automatically with the Prokka 
1.10 software (Rapid Bacterial Genome Annotation) [28], 
with the default parameters and nested databases in the 
order: TrEMBL Uniprot containing only (Pepto) Clostrid-
ium spp. proteins and RefSeq database. The genome was 
also curated manually in all putative frameshifts using 
the Artemis software [29], based on the coverage visu-
alized with the CLC Genomics Workbench 7 software, 
with corrected indel assembly bias. Genes encoding sig-
nal peptides were identified with the SignalP 4.0 software 
[30] on a local installation, followed by the identification 
of transmembrane helices with Tmhmm 2.0 [31] and 
a Pfam domain search with PfamScan [32]. These three 
tools were used with their default parameters.
Multilocus sequence typing (MLST) and in silico PCR
MLST was performed with PubMLST (available at http://
pubmlst.org/cdifficile/) using the complete genome 
sequence. An in silico PCR search for genes related to 
virulence factors and antimicrobial resistance was per-
formed with the jPCR software [33], with the default 
parameters and the primer sets shown in Additional 
file 2.
Quality assurance
Genomic DNA was isolated from a pure bacterial isolate 
and confirmed with 16S rRNA gene sequencing. All the 
raw sequencing data were mapped onto the final genome 
and the lack of contamination with other genomes 
was confirmed by the coverage and the low number of 
unmapped reads.
An alignment was constructed with the 16S rRNA 
sequence regions on the assembled scaffolds, predicted 
with the Barrnap software (available at https://github.
com/tseemann/barrnap), and the 16S rRNA genes of 
genomes available in GenBank. A phylogenetic tree was 
constructed from this alignment with the neighbor-
joining method based on 1000 randomly selected boot-
strap replicates, using the CLC Genomic Workbench 7.0 
software. On the tree, strain Z31 was positioned among 
other P. difficile strains (Fig. 2).
Results and discussion
After the genome assembly, gap filling, and annotation 
process, an in silico PCR was performed through search-
ing for genes related to virulence factor, antibiotic resist-
ance, and other known toxins. Considering the perspective 
of using the nontoxigenic strain Z31 to prevent PDI by 
competitive exclusion, some non-toxin virulence factors 
Fig. 2 Phylogenetic tree of Peptoclostridium difficile strain Z31 representing the relative position in the genus Peptoclostridium based on 16S 
sequences. The statistical method used was maximum likelihood and the bootstrap number was 1000. Thus, the values next to the nodes represent 
the percentage on the number of times, in 1000 repetitions, in which that clade was formed
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are desirable, predominantly those factors responsible for 
spore production and stability and those that promote 
cell attachment and host colonization. Z31 is positive for 
Cwp84 and surface-layer protein A (SlpA). SlpA is consid-
ered the major factor responsible for bacterial intestinal 
adherence, and Cwp84 is essential for the formation of that 
protein [34, 35]. GroEL, Cwp66, and a fibronectin-bind-
ing protein (Fbp68), which are also important in host-cell 
adherence, were also found [34–38]. Strain Z31 was also 
positive for genes encoding the flagellar proteins FliC and 
FliD, which play roles in the colonization and adherence 
of Z31 in  vivo and are essential in later stages of biofilm 
formation [39–41]. These factors found in Z31 related to 
cell attachment are extremely important, because non 
toxigenic strains have to be able to compete with toxigenic 
strains by the colonization sites to prevent the disease [23].
The gene encoding the major regulator of sporula-
tion in P. difficile, Spo0A, was detected in this strain. An 
absence or deficiency of Spo0A can cripple or impair 
the sporulation process [35, 42]. Genes encoding five 
spore coat proteins (cotA, cotB, cotC, cotD, and sodA) 
were also detected. The cotA protein is the most impor-
tant protein in stabilizing the spore coat and ensures the 
integrity of this structure [43]. The formation of stable 
spores is also important for a nontoxigenic strain can-
didate to prevent the disease, because the bacteria need 
to pass through the stomach and be able to colonize 
the colon [23]. Vegetative cells are sensible to low pH, 
on the other hand, the spores resist to this conditions, 
allowing a great number of viable particles reaches 
the colon [44]. Genes responsible for resistance to tet-
racycline (tetM) and erythromycin (ermG) were also 
detected with previously described PCR primers [45, 
46]. In contrast, none of the genes encoding proteins 
directly linked to toxin production were detected (tcdA, 
tcdB, tcdC, cdtA, or cdtB) [47] confirming the absence of 
the pathogenicity locus (PaLoc), which is essential for P. 
difficile infection [48].
Furthermore, the complete genomes of this species 
available at GenBank were selected to perform a similar-
ity analysis with Gegenees software [49] with sequence 
fragmentation length of 500 nucleotides and a threshold 
of 30  %. Also, two complete genomes of species of the 
Clostridium genus were included as an outgroup. The 
similarity matrix was used to generate a heatplot and a 
“.nexus” format for phylogenomic analysis (Additional 
file 3). Although the Z31 strain is a nontoxigenic strain, 
the Additional file  3 shows that clade of this strain is 
paraphyletic with the type strain ATCC9689, a known as 
toxigenic strain, suggesting an evolutionary derivation of 
a same organism. Thereby, the nontoxigenic behavior of 
the Z31 strain seems to be occasioned by the losses of the 
toxin genes.
Initial findings
The P. difficile genome is composed of a circular chromo-
some of 4298,263 bp. The GC content is 29.21 % and the 
genome contains 78 pseudogenes. Briefly, the genome 
has 4206 CDSs, and encodes 29 rRNAs, one transfer–
messenger RNA (tmRNA), and 58 tRNAs. Table 1 sum-
marizes the subset of the 3809 genes with predicted 
functions that are associated with each COG functional 
categories. In summary, 3324 genes were predicted to 
have Pfam domains, 166 to have signal peptides, and 
1011 to have transmembrane helices. No CRISPR repeats 
were found. Figure  3 shows the disposition of RNAs 
and CDSs coding sequences on the forward and reverse 
strands, the GC content, and the GC skew.
When the genome of Z31 was compared with 
those of other P. difficile strains deposited in Gen-
Bank [50], it showed high similarity to them 
Table 1 Number of  genes associated with  general COG 
functional categories [55]
a The percentage is based on the total number of protein coding genes in the 
annotated genome
b The total not correspond to the final quantity of CDSs for each genome, 
because some genes are associated with more than one COG functional 
categories
Code Valueb %agea Description
J 238 5.6585 Translation, ribosomal structure and biogen-
esis
A 0 0 RNA processing and modification
K 479 11.3884 Transcription
L 184 4.3747 Replication, recombination and repair
B 1 0.0237 Chromatin structure and dynamics
D 68 1.6167 Cell cycle control, cell division, chromosome 
partitioning
V 134 3.1859 Defense mechanisms
T 327 7.7746 Signal transduction mechanisms
M 208 4.9453 Cell wall/membrane biogenesis
N 79 1.8782 Cell motility
U 40 0.9510 Intracellular trafficking and secretion
O 111 2.6390 Posttranslational modification, protein turno-
ver, chaperones
C 219 5.2068 Energy production and conversion
G 310 7.3704 Carbohydrate transport and metabolism
E 321 7.6319 Amino acid transport and metabolism
F 93 2.2111 Nucleotide transport and metabolism
H 147 3.4950 Coenzyme transport and metabolism
I 89 2.1160 Lipid transport and metabolism
P 168 3.9942 Inorganic ion transport and metabolism
Q 57 1.3552 Secondary metabolites biosynthesis, transport 
and catabolism
R 345 8.2025 General function prediction only
S 251 5.9676 Function unknown
– 2 0.0475 Not in COGs
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(95.50  ±  2.68  %—Additional file  3), with the exception 
of some genomic islands (Fig.  3), four of which were 
predicted with PHAST [51] to be phage regions. A brief 
description of these phages is given in Table 2.
A robust high-throughput MLST scheme for P. difficile 
was developed and validated [52], and allowed this spe-
cies to be genotyped directly. Z31 was typed with MLST 
at loci adk 1, atpA 1, dxr 2, glyA 1, recA 1, sodA 1, and 
tpi 1, which classified this strain as ST3 in MLST clade 1. 
This result corroborates previous work, which reported 
that strains from PCR ribotype 009 are commonly clas-
sified as ST3 [53]. Strain Z31, P. difficile ATCC9689/
DSM1296, and P. difficile BI9 were the only three ST3 
strains identified among the strains whose complete 
genomes or near-complete genomes (e.g., one scaffold) 
are deposited in GenBank. However, Z31 contain some 
unique regions, as shown in Fig. 3 (U1–U12). In contrast, 
P. difficile 5.3, described as nontoxigenic by Darling et al. 
[54], belongs to ST15, clade  1, a common classification 
for strains of PCR ribotype 010.
Future directions
Further analysis of the P. difficile Z31 genome will provide 
new information about the adaptation of this strain to the 
gastrointestinal tract, and new insights into its inhibition 
of toxigenic P. difficile strains.
Fig. 3 Graphical circular map of Peptoclostridium difficile strain Z31 genome. From outside to the center: predicted phage regions by PHAST; RNAs; 
CDSs on reverse strand; CDSs on forward strand; Blastn hits with BI9, BJ08, ATCC9689/DSM1296, BI1, 2007855, M120, CF5, CD196, CD630DERM, 
CD630, Cd5.3 strains; GC skew; and, GC content
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Availability of supporting data
This whole-genome shotgun sequence has been depos-
ited in the DDBJ/EMBL/GenBank databases under acces-
sion number CP013196. The version described in this 
paper is the first version CP013196.1.
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